Science

Hantavirus Diagnostics Under Scrutiny: RT-PCR, Serology, and West African Lab Capacity

As the MV Hondius Andes hantavirus outbreak continues, diagnostic testing strategies are critical. Experts weigh the utility of RT-PCR versus serology, highlighting detection timelines, potential cross-reactivity, and the pressing need for enhanced laboratory infrastructure in West Africa.

HCD

Hantavirus Cruise Desk

Outbreak Tracking Team · September 23, 2026 · 5 min read

Hantavirus Diagnostics Under Scrutiny: RT-PCR, Serology, and West African Lab Capacity

Diagnostic Challenges Define Hantavirus Response

The ongoing hantavirus event aboard the MV Hondius Andes, anchored off Praia, Cape Verde, continues to underscore bigly challenges in timely and accurate diagnostic testing. Public health agencies and infectious disease experts are grappling with the intricacies of identifying active infections versus past exposures, particularly in a region with varying laboratory capabilities. The debate centers on the optimal application of Real-Time Polymerase Chain Reaction (RT-PCR) and serological assays, each with distinct advantages and limitations.

RT-PCR: Early Detection, Limited Window

RT-PCR testing directly detects hantavirus genetic material. Its primary advantage lies in its ability to identify acute infections early in the disease course, often before the body mounts a detectable antibody response. This is crucial for early case identification, isolation, and contact tracing, which are vital for outbreak control. Yet, the window for effective RT-PCR detection is relatively narrow. Viral RNA levels tend to be highest during the initial viremic phase, typically appearing shortly after symptom onset and often declining as the immune response develops. If samples are collected too late in the illness, RT-PCR may yield false-negative results, even if the patient is indeed infected. And, the sensitivity can be influenced by the quality of the sample (e.g., blood, urine, respiratory secretions), timing of collection, and specific primers used to target the viral genome.

Serology: Past Exposure and Later Stage Confirmation

Serological tests, primarily Enzyme-Linked Immunosorbent Assays (ELISA) or immunofluorescence assays (IFA), detect antibodies (IgM and IgG) produced by the body in response to hantavirus infection. IgM antibodies typically appear within days to a week after symptom onset and can persist for several weeks or months, indicating a recent infection. IgG antibodies develop later, usually within two to four weeks, and can persist for years, signifying past exposure or recovery. Serology is particularly valuable for confirming infections in patients presenting later in their illness when viremia might have subsided, making RT-PCR less effective. It also plays a critical role in epidemiological studies, allowing public health officials to assess population exposure rates. Though, serology is not ideal for very early diagnosis. A negative serology result in the initial days of symptoms doesn't rule out infection, necessitating repeat testing or RT-PCR.

The Confounding Factor of Cross-Reactivity

A bigly concern with serological testing for hantaviruses, especially in regions where multiple hantavirus species circulate or where related viral infections are prevalent, is cross-reactivity. Antibodies generated against one hantavirus species can sometimes react with antigens from other hantavirus species, leading to false-positive results or making it difficult to pinpoint the exact causative strain. This can complicate diagnosis and epidemiological investigations, potentially overestimating case numbers or misidentifying the circulating virus. For example, while different hantavirus species cause distinct clinical syndromes (e.g., Hemorrhagic Fever with Renal Syndrome (HFRS) vs. Hantavirus Pulmonary Syndrome (HPS)), the serological cross-reactivity between species can be problematic.Confirmatory testing, such as Western blot or neutralization assays, may be required to differentiate specific infections. These methods are often more complex and less accessible for routine diagnostic use.

West African Laboratory Capacity: A Critical Bottleneck

The effective deployment of both RT-PCR and serological diagnostics is heavily reliant on strong laboratory infrastructure and trained personnel. In West Africa, including nations surrounding Cape Verde, laboratory capacity for highly specialized viral diagnostics remains a persistent challenge. While bigly strides have been made in enhancing diagnostic capabilities, particularly following previous outbreaks of other viral hemorrhagic fevers, gaps persist. Key issues include:

Availability of Reagents and Kits: Consistent supply chains for specialized hantavirus diagnostic kits, including those for RT-PCR and serology, can be tenuous. * Equipment and Maintenance: Sophisticated equipment required for RT-PCR (e.g., thermocyclers) and ELISA (e.g., plate readers) demands regular maintenance and calibration, which can be difficult in resource-limited settings. * Trained Personnel: A shortage of highly skilled laboratory technicians and molecular biologists capable of performing complex diagnostic assays, interpreting results. Troubleshooting technical issues is a critical bottleneck. * Biosafety Levels: Handling hantavirus samples requires specific biosafety measures (typically BSL-2 or BSL-3 for viral culture), and not all regional labs possess these capabilities. * Reference Laboratories: The ability to send samples to regional or international reference laboratories for confirmatory testing, particularly in cases of inconclusive results or for strain identification, is crucial yet can be hampered by logistics and customs procedures. International organizations such as the World Health Organization (WHO) and Africa Centres for Disease Control and Prevention (Africa CDC) have been actively supporting capacity building. But, the current outbreak on the MV Hondius Andes highlights the urgent need for continued investment and sustained support for diagnostic laboratories across the region. Improving local capabilities for timely and accurate hantavirus diagnostics is paramount for mitigating the impact of the current event and enhancing preparedness for future outbreaks.

Moving Forward: Integrated Diagnostic Approaches

Experts advocate for an integrated diagnostic approach, utilizing both RT-PCR and serology judiciously. Early suspected cases should ideally be screened with RT-PCR. Serology can then complement this by confirming later-stage infections and contributing to epidemiological understanding. For the MV Hondius Andes outbreak, this means ensuring that samples can be rapidly transported and processed by equipped laboratories, whether on shore or through mobile facilities.